Alzheimer's disease: One disorder, too many genes?

Human Molecular Genetics

Volumn 13, Issue REV. ISS. 1, 2004, Pages

  Bertram, Lars ^a   Tanzi, Rudolph E ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

ALZHEIMER DISEASE; ANALYTICAL ERROR; CHROMOSOME 10Q; CHROMOSOME 11Q; CHROMOSOME 6P; EVIDENCE BASED MEDICINE; GENE IDENTIFICATION; GENE LOCUS; GENE REPLICATION; GENE STRUCTURE; GENETIC ANALYSIS; GENOME ANALYSIS; HAPLOTYPE; HUMAN; MEDICAL RESEARCH; PRIORITY JOURNAL; REVIEW; STRUCTURE ANALYSIS;

ALZHEIMER DISEASE; CHROMOSOMES, HUMAN; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; HUMANS;

EID: 1842507631     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (67)

1. Rao, V.S., Cupples, A., van Duijn, C.M., Kurz, A., Green, R.C., Chui, H., Duara, R., Auerbach, S.A., Volicer, L., Wells, J. et al. (1996) Evidence for major gene inheritance of Alzheimer disease in families of patients with and without apolipoprotein E epsilon 4. Am. J. Hum. Genet., 59, 664-675.
2. Bergem, A.L., Engedal, K. and Kringlen, E. (1997) The role of heredity in late-onset Alzheimer disease and vascular dementia. A twin study. Arch. Gen. Psychiat., 54, 264-270.
3. Daw, E.W., Payami, H., Nemens, E.J., Nochlin, D., Bird, T.D., Schellenberg, G.D. and Wijsman, E.M. (2000) The number of trait loci in late-onset Alzheimer disease. Am. J. Hum. Genet., 66, 196-204.
4. Kennedy, J.L., Farrer, L.A., Andreasen, N.C., Mayeux, R. and St George-Hyslop, P. (2003) The genetics of adult-onset neuropsychiatric disease: Complexities and conundra? Science, 302, 822-826.
5. McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D. and Stadlan, E.M. (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology, 34, 939-944.
6. Kosunen, O., Soininen, H., Paljarvi, L., Heinonen, O., Talasniemi, S. and Riekkinen, P.J. Sr. (1996) Diagnostic accuracy of Alzheimer's disease: A neuropathological study. Acta Neuropathol. (Berl.), 91, 185-193.
7. Rasmusson, D.X., Brandt, J., Steele, C., Hedreen, J.C., Troncoso, J.C. and Folstein, M.F. (1996) Accuracy of clinical diagnosis of Alzheimer disease and clinical features of patients with non-Alzheimer disease neuropathology. Alzheimer Dis. Assoc. Disord., 10, 180-188.
8. Blacker, D., Bertram, L., Saunders, A.J., Moscarillo, T.J., Albert, M.S., Wiener, H., Perry, R.T., Collins, J.S., Harrell, L.E., Go, R.C. et al. (2003) Results of a high-resolution genome screen of 437 Alzheimer's disease families. Hum. Mol. Genet., 12, 23-32.
9. Pericak-Vance, M.A., Bass, M.P., Yamaoka, L.H., Gaskell, P.C., Scott, W.K., Terwedow, H.A., Menold, M.M., Conneally, P.M., Small, G.W., Vance, J.M. et al. (1997) Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12. JAMA, 278, 1237-1241.
10. Zubenko, G.S., Hughes, H.B., Stiffler, J.S., Hurtt, M.R. and Kaplan, B.B. (1998) A genome survey for novel Alzheimer disease risk loci: Results at 10-cM resolution. Genomics, 50, 121-128.
11. Kehoe, P., Wavrant-De Vrieze, F., Crook, R., Wu, W.S., Holmans, P., Fenton, I., Spurlock, G., Norton, N., Williams, H., Williams, N. et al. (1999) A full genome scan for late onset Alzheimer's disease. Hum. Mol. Genet., 8, 237-245.
12. Pericak-Vance, M.A., Grubber, J., Bailey, L.R., Hedges, D., West, S., Santoro, L., Kemmerer, B., Hall, J.L., Saunders, A.M., Roses, A.D. et al. (2000) Identification of novel genes in late-onset Alzheimer's disease. Exp. Gerontol., 35, 1343-1352.
13. Curtis, D., North, B.V. and Sham, P.C. (2001) A novel method of two-locus linkage analysis applied to a genome scan for late onset Alzheimer's disease. Ann. Hum. Genet., 65, 473-481.
14. Hiltunen, M., Mannermaa, A., Thompson, D., Easton, D., Pirskanen, M., Helisalmi, S., Koivisto, A.M., Lehtovirta, M., Ryynanen, M. and Soininen, H. (2001) Genome-wide linkage disequilibrium mapping of late-onset Alzheimer's disease in Finland. Neurology, 57, 1663-1668.
15. Li, Y.J., Scott, W.K., Hedges, D.J., Zhang, F., Gaskell, P.C., Nance, M.A., Watts, R.L., Hubble, J.P., Koller, W.C., Pahwa, R. et al. (2002) Age at onset in two common neurodegenerative diseases is genetically controlled. Am. J. Hum. Genet., 70, 985-993.
16. Myers, A., Wavrant De-Vrieze, F., Holmans, P., Hamshere, M., Crook, R., Compton, D., Marshall, H., Meyer, D., Shears, S., Booth, J. et al. (2002) Full genome screen for Alzheimer disease: Stage II analysis. Am. J. Med. Genet., 114, 235-244.
17. Olson, J.M., Goddard, K.A. and Dudek, D.M. (2002) A second locus for very-late-onset Alzheimer disease: A genome scan reveals linkage to 20p and epistasis between 20p and the amyloid precursor protein region. Am. J. Hum. Genet., 71, 154-161.
18. Farrer, L.A., Bowirrat, A., Friedland, R.P., Waraska, K., Korczyn, A.D. and Baldwin, C.T. (2003) Identification of multiple loci for Alzheimer disease in a consanguineous Israeli-Arab community. Hum. Mol. Genet., 12, 415-422.
19. Scott, W.K., Hauser, E.R., Schmechel, D.E., Welsh-Bohmer, K.A., Small, G.W., Roses, A.D., Saunders, A.M., Gilbert, J.R., Vance, J.M., Haines, J.L. et al. (2003) Ordered-subsets linkage analysis detects novel Alzheimer disease Loci on chromosomes 2q34 and 15q22. Am. J. Hum. Genet., 73, 1041-1051.
20. Bird, T.D., Jarvik, G.P. and Wood N.W. (2001) Genetic association studies: Genes in search of diseases. Neurology, 57, 1153-1154.
21. Cardon, L.R. and Bell, J.I. (2001) Association study designs for complex diseases. Nat. Rev. Genet., 2, 91-99.
22. Poirier, J. (2000) Apolipoprotein E and Alzheimer's disease. A role in amyloid catabolism. Ann. NY Acad. Sci., 924, 81-90.
23. Holtzman, D.M. (2001) Role of apoe/Abeta interactions in the pathogenesis of Alzheimer's disease and cerebral amyloid angiopathy. J. Mol. Neurosci., 17, 147-155.
24. Vecchio, T.J. (1966) Predictive value of a single diagnostic test in unselected populations. New Engl. J. Med., 274, 1171-1173.
25. Ioannidis, J.P., Ntzani, E.E., Trikalinos, T.A. and Contopoulos-Ioannidis, D.G. (2001) Replication validity of genetic association studies. Nat. Genet., 29, 306-309.
26. Pfeiffer, R.M. and Gail, M.H. (2003) Sample size calculations for population- and family-based case-control association studies on marker genotypes. Genet. Epidemiol., 25, 136-148.
27. Bertram, L. and Tanzi, R.E. (2001) Of replications and refutations: The status of Alzheimer's disease genetic research. Curr. Neurol. Neurosci. Rep., 1, 442-450.
28. Cooper, D.N., Nussbaum, R.L. and Krawczak, M. (2002) Proposed guidelines for papers describing DNA polymorphism-disease associations. Hum. Genet., 110, 207-208.
29. Tabor, H.K., Risch, N.J. and Myers, R.M. (2002) Opinion: candidate-gene approaches for studying complex genetic traits: Practical considerations. Nat. Rev. Genet., 3, 391-397.
30. Gabriel, S.B., Schaffner, S.F., Nguyen, H., Moore, J.M., Roy, J., Blumenstiel, B., Higgins, J., DeFelice, M., Lochner, A., Faggart, M. et al. (2002) The structure of haplotype blocks in the human genome. Science, 296, 2225-2229.
31. Cardon, L.R. and Abecasis, G.R. (2003) Using haplotype blocks to map human complex trait loci. Trends Genet, 19, 135-140.
32. Conrad. C., Andreadis, A., Trojanowski, J.Q., Dickson, D.W., Kang, D., Chen, X., Wiederholt, W., Hansen, L., Masliah, E., Thal, L.J. et al. (1997) Genetic evidence for the involvement of tau in progressive supranuclear palsy. Ann. Neurol., 41, 277-281.
33. Horikawa, Y., Oda, N., Cox, N.J., Li, X., Orho-Melander, M., Hara, M., Hinokio, Y., Lindner, T.H., Mashima, H., Schwarz, P.E. et al. (2000) Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat. Genet., 26, 163-175.
34. Rioux, J.D., Daly, M.J., Silverberg, M.S., Lindblad, K., Steinhart, H., Cohen, Z., Delmonte, T., Kocher, K., Miller, K., Guschwan, S. et al. (2001) Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat. Genet., 29, 223-228.
35. Martin, E.R., Lai, E.H., Gilbert, J.R., Rogala, A.R., Afshari, A.J., Riley, J., Finch, K.L., Stevens, J.F., Livak, K.J., Slotterbeck, B.D. et al. (2000) SNPing away at complex diseases: Analysis of single-nucleotide polymorphisms around APOE in Alzheimer disease. Am. J. Hum. Genet., 67, 383-394.
36. Fallin, D., Cohen, A., Essioux, L., Chumakov, I., Blumenfeld, M., Cohen, D. and Schork, N.J. (2001) Genetic analysis of case/control data using estimated haplotype frequencies: Application to APOE locus variation and Alzheimer's disease. Genome Res., 11, 143-151.
37. Wilcox, C.B., Caspary, E.A. and Behan, P.O. (1980) Histocompatibility antigens in Alzheimer's disease. A preliminary study. Eur. Neurol., 19, 262-265.
38. Culpan, D., MacGowan, S.H., Ford, J.M., Nicoll, J.A., Griffin, W.S., Dewar, D., Cairns, N.J., Hughes, A., Kehoe, P.G. and Wilcock, G.K. (2003) Tumour necrosis factor-alpha gene polymorphisms and Alzheimer's disease. Neurosci. Lett., 350, 61-65.
39. Pulliam, J.F., Jennings, C.D., Kryscio, R.J., Davis, D.G., Wilson, D., Montine, T.J., Schmitt, F.A. and Markesbery, W.R. (2003) Association of HFE mutations with neurodegeneration and oxidative stress in Alzheimer's disease and correlation with APOE. Am. J. Med. Genet., 119B, 48-53.
40. Candore, G., Licastro, F., Chiappelli, M., Franceschi, C., Lio, D., Rita Balistreri, C., Piazza, G., Colonna-Romano, G., Grimaldi, L.M. and Caruso, C. (2003) Association between the HFE mutations and unsuccessful ageing: A study in Alzheimer's disease patients from Northern Italy. Mech. Ageing Dev., 124, 525-528.
41. Terreni, L., Fogliarino, S., Quadri, P., Ruggieri, R.M., Piccoli, F., Tettamanti, M., Lucca, U. and Forloni, G. (2003) Tumor necrosis factor alpha polymorphism C-850T is not associated with Alzheimer's disease and vascular dementia in an Italian population. Neurosci. Lett., 344, 135-137.
42. Clarimon, J., Bertranpetit, J., Boada, M., Tarraga, L. and Comas, D. (2003) HSP70-2 (HSPA1B) is associated with noncognitive symptoms in late-onset Alzheimer's disease. J. Geriatr. Psychiat. Neurol., 16, 146-150.
43. Clarimon, J., Bertranpetit, J., Calafell, F., Boada, M., Tarraga, L. and Comas, D. (2003) Joint analysis of candidate genes related to Alzheimer's disease in a Spanish population. Psychiatr. Genet., 13, 85-90.
44. Nourhashemi, F., Gillette-Guyonnet, S., Fort, M., Andrieu, S., Abbal, M., Albarede, J.L. and Vellas, B. (2003) [Association between the A2 allele of the HLA system and age at onset of Alzheimer's disease]. Presse Med, 32, 158-161.
45. Akiyama, H., Barger, S., Barnum, S., Bradt, B., Bauer, J., Cole, G.M., Cooper, N.R., Eikelenboom, P., Emmerling, M., Fiebich, B.L. et al. (2000) Inflammation and Alzheimer's disease. Neurobiol. Aging, 21, 383-421.
46. Edland, S.D., Wavrant-De Vriese, F., Compton, D., Smith, G.E., Ivnik, R., Boeve, B.F., Tangalos, E.G. and Petersen, R.C. (2003) Insulin degrading enzyme (IDE) genetic variants and risk of Alzheimer's disease: Evidence of effect modification by apolipoprotein E (APOE). Neurosci. Lett., 345, 21-24.
47. Feuk, L., Prince, J.A., Blennow, K. and Brookes, A.J. (2003) Further evidence for role of a promoter variant in the TNFRSF6 gene in Alzheimer disease. Hum. Mutat., 21, 53-60.
48. Prince, J.A., Feuk, L., Gu, H.F., Johansson, B., Gatz, M., Blennow, K. and Brookes, A.J. (2003) Genetic variation in a haplotype block spanning IDE influences Alzheimer disease. Hum. Mutat., 22, 363-371.
49. Qiu, W.Q., Walsh, D.M., Ye, Z., Vekrellis, K., Zhang, J., Podlisny, M.B., Rosner, M.R., Safavi, A., Hersh, L.B. and Selkoe, D.J. (1998) Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation. J. Biol. Chem., 273, 32730-32738.
50. Farris, W., Mansourian, S., Chang, Y., Lindsley, L., Eckman, E.A., Frosch, M.P., Eckman, C.B., Tanzi, R.E., Selkoe, D.J. and Guenette, S. (2003) Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. Proc. Natl Acad. Sci. USA, 100, 4162-4167.
51. Miller, B.C., Eckman, E.A., Sambamurti, K., Dobbs, N., Chow, K.M., Eckman, C.B., Hersh, L.B. and Thiele, D.L. (2003) Amyloid-beta peptide levels in brain are inversely correlated with insulysin activity levels in vivo. Proc. Natl Acad. Sci. USA, 100, 6221-6226.
52. Leissring, M.A., Farris, W., Chang, A.Y., Walsh, D.M., Wu, X., Sun, X., Frosch, M.P. and Selkoe, D.J. (2003) Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death. Neuron, 40, 1087-1093.
53. Bertram, L., Blacker, D., Mullin, K., Keeney, D., Jones, J., Basu, S., Yhu, S., McInnis, M.G., Go, R.C., Vekrellis, K. et al. (2000) Evidence for genetic linkage of Alzheimer's disease to chromosome 10q. Science, 290, 2302-2303.
54. Ait-Ghezala, G., Abdullah, L., Crescentini, R., Crawford, F., Town, T., Singh, S., Richards, D., Duara, R. and Mullan, M. (2002) Confirmation of association between D10S583 and Alzheimer's disease in a case-control sample. Neurosci. Lett., 325, 87-90.
55. Abraham, R., Myers, A., Wavrant-DeVrieze, F., Hamshere, M.L., Thomas, H.V., Marshall, H., Compton, D., Spurlock, G., Turic, D., Hoogendoorn, B. et al. (2001) Substantial linkage disequilibrium across the insulin-degrading enzyme locus but no association with late-onset Alzheimer's disease. Hum. Genet., 109, 646-652.
56. Boussaha, M., Hannequin, D., Verpillat, P., Brice, A., Frebourg, T. and Campion, D. (2002) Polymorphisms of insulin degrading enzyme gene are not associated with Alzheimer's disease. Neurosci. Lett., 329, 121-123.
57. Johansson, A., Hampel, H., Faltraco, F., Buerger, K., Minthon, L., Bogdanovic, N., Sjogren, M., Zetterberg, H., Forsell, L., Lilius, L. et al. (2003) Increased frequency of a new polymorphism in the cell division cycle 2 (cdc2) gene in patients with Alzheimer's disease and frontotemporal dementia. Neurosci. Lett., 340, 69-73.
58. Li, Y.J., Oliveira, S.A., Xu, P., Martin, E.R., Stenger, J.E., Scherzer, C.R., Hauser, M.A., Scott, W.K., Small, G.W., Nance, M.A. et al. (2003) Glutathione S-transferase omega-1 modifiesage-at-onset of Alzheimer disease and Parkinson disease. Hum. Mol. Genet., 12, 3259-3267.
59. Gold, G., Blouin, J.L., Herrmann, F.R., Michon, A., Mulligan, R., Duriaux Sail, G., Bouras, C., Giannakopoulos, P. and Antonarakis, S.E. (2003) Specific BACE1 genotypes provide additional risk for late-onset Alzheimer disease in APOE epsilon 4 carriers. Am. J. Med. Genet., 119B, 44-47.
60. Kirschling, C.M., Kolsch, H., Frahnert, C., Rao, M.L., Maier, W. and Heun, R. (2003) Polymorphism in the BACE gene influences the risk for Alzheimer's disease. Neuroreport, 14, 1243-1246.
61. Clarimon, J., Bertranpetit, J., Calafell, F., Boada, M., Tarraga, L. and Comas, D. (2003) Association study between Alzheimer's disease and genes involved in Abeta biosynthesis, aggregation and degradation: Suggestive results with BACE1. J. Neurol., 250, 956-961.
62. Nowotny, P., Kwon, J.M., Chakraverty, S., Nowotny, V., Morris, J.C. and Goate, A.M. (2001) Association studies using novel polymorphisms in BACE1 and BACE2. Neuroreport, 12, 1799-1802.
63. Cruts, M., Dermaut, B., Rademakers, R., Roks, G., Van den Broeck, M., Munteanu, G., van Duijn, C.M. and Van Broeckhoven, C. (2001) Amyloid beta secretase gene (BACE) is neither mutated in nor associated with early-onset Alzheimers disease. Neurosci. Lett., 313, 105-107.
64. Murphy, T., Yip, A., Brayne, C., Easton, D., Evans, J.G., Xuereb, J., Cairns, N., Esiri, M.M. and Rubinsztein, D.C. (2001) The BACE gene: Genomic structure and candidate gene study in late-onset Alzheimer's disease. Neuroreport, 12, 631-634.
65. Nicolaou, M., Song, Y.Q., Sato, C.A., Orlacchio, A., Kawarai, T., Medeiros, H., Liang, Y., Sorbi, S., Richard, E., Rogaev, E.I. et al. (2001) Mutations in the open reading frame of the beta-site APP cleaving enzyme (BACE) locus are not a common cause of Alzheimer's disease. Neurogenetics, 3, 203-206.
66. Liu, H.C., Leu, S.J., Chang, J.G., Sung, S.M., Hsu, W.C., Lee, L.S. and Hu, C.J. (2003) The association of beta-site APP cleaving enzyme (BACE) C786G polymorphism with Alzheimer's disease. Brain Res., 961, 88-91.
67. Shi, J., Zhang, S., Tang, M., Liu, X., Li, T., Wang, Y., Han, H., Guo, Y., Hao, Y., Zheng, K. et al. (2004) The 1239G/C polymorphism in exon 5 of BACE1 gene may be associated with sporadic Alzheimer's disease in Chinese Hans. Am. J. Med. Genet., 124B, 54-57.